Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy

por Yoshida, Sumito, Shime, Hiroaki, Matsumoto, Misako, Kasahara, Masanori, Seya, Tsukasa
Publicado 2019

Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells

por Shime, Hiroaki, Maruyama, Akira, Yoshida, Sumito, Takeda, Yohei, Matsumoto, Misako, Seya, Tsukasa
Publicado 2017

Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy

por SEYA, Tsukasa, TAKEDA, Yohei, TAKASHIMA, Ken, YOSHIDA, Sumito, AZUMA, Masahiro, MATSUMOTO, Misako
Publicado 2018

The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages

por Yoshida, Sumito, Shime, Hiroaki, Funami, Kenji, Takaki, Hiromi, Matsumoto, Misako, Kasahara, Masanori, Seya, Tsukasa
Publicado 2017

Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models

por Takeda, Yohei, Yoshida, Sumito, Takashima, Ken, Ishii‐Mugikura, Noriko, Shime, Hiroaki, Seya, Tsukasa, Matsumoto, Misako
Publicado 2018

Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model

por Yoshida, Sumito, Shime, Hiroaki, Takeda, Yohei, Nam, Jin‐Min, Takashima, Ken, Matsumoto, Misako, Shirato, Hiroki, Kasahara, Masanori, Seya, Tsukasa
Publicado 2018

The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc(Min/+) mice

por Ono, Junya, Shime, Hiroaki, Takaki, Hiromi, Takashima, Ken, Funami, Kenji, Yoshida, Sumito, Takeda, Yohei, Matsumoto, Misako, Kasahara, Masanori, Seya, Tsukasa
Publicado 2017